Elective neck irradiation
Showing 26 - 50 of 9,830
Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +2 more
- Optimisation of dental implant sites protection from irradiation
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Aug 2, 2022
Head and Neck Tumors, Deglutition Disorders Trial in Milwaukee (Expiratory Muscle Strength Training, Pharyngeal Muscle
Recruiting
- Head and Neck Neoplasms
- Deglutition Disorders
- Expiratory Muscle Strength Training
- Pharyngeal Muscle Strengthening Exercises
-
Milwaukee, Wisconsin
- +1 more
May 16, 2022
Breast Tumors Trial in Seoul (Internal mammary node irradiation, No internal mammary node irradiation)
Active, not recruiting
- Breast Neoplasms
- Internal mammary node irradiation
- No internal mammary node irradiation
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Mar 16, 2021
Squamous Cell Carcinoma of Head and Neck Trial in Modena (Non elective radiotherapy)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- Non elective radiotherapy
-
Modena, ItalyAOUPoliclinicoModena
Apr 1, 2021
NC/TMD Ratio as a Difficult Airway Predictor in Obese Patients
Recruiting
- Difficult / Failed Intubation
-
Islamabad, ICT, PakistanKRL Hospital
Feb 20, 2023
Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease Trial in New York (OBP-301,
Terminated
- Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
-
New York, New YorkWeill Cornell Medicine
Jul 6, 2022
Head and Neck Tumors, Carcinoma, Squamous Cell Trial in Netherlands (standard dose prescription, FDG-PET guided gradient dose
Active, not recruiting
- Head and Neck Neoplasms
- Carcinoma, Squamous Cell
- standard dose prescription
- FDG-PET guided gradient dose prescription
-
Amsterdam, Netherlands
- +4 more
Jan 25, 2022
Locally Recurrent Head and Neck Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Sinonasal Squamous Cell
Recruiting
- Locally Recurrent Head and Neck Squamous Cell Carcinoma
- +2 more
- Birinapant
- Intensity-Modulated Radiation Therapy
-
Birmingham, Alabama
- +32 more
Aug 20, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Canada, United States (Pembrolizumab, Stereotactic Body Radiation Therapy
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Pembrolizumab
- Stereotactic Body Radiation Therapy (SBRT)
-
Tucson, Arizona
- +18 more
Jul 18, 2022
Squamous Cell Head Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction Trial run by the (AAV2hAQP1)
Recruiting
- Squamous Cell Head and Neck Cancer
- +2 more
- AAV2hAQP1
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2022
Head and Neck Squamous Cell Carcinoma Trial in Dallas (Intensity modulated radiation therapy (IMRT))
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Intensity modulated radiation therapy (IMRT)
-
Dallas, TexasUniversity of Texas Southwestern Medical Center - Dallas
Nov 18, 2022
Diffuse Intrinsic Pontine Glioma Trial in Milan (Nimotuzumab, Vinorelbine, Radiotherapy)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Nimotuzumab
- +2 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the
Recruiting
- Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
- +2 more
- Atezolizumab
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jan 19, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Not yet recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Carboplatin
- +9 more
- (no location specified)
Jan 31, 2023
Recurrent Head and Neck Squamous Cell Carcinoma, Second Primary Squamous Cell Carcinoma of the Head and Neck Trial in Houston
Recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- Second Primary Squamous Cell Carcinoma of the Head and Neck
- Bintrafusp Alfa
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2021
Ventilation With Supraglottic Airway Devices
Completed
- Laryngeal Masks Comparison
- Air-Q Self Pressurized Airway Device with Blocker
- I-Gel
-
Cairo, EgyptDepartment of anesthesia, Surgical ICU and Pain Management
Aug 1, 2021
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma Trial in Canada,
Recruiting
- Buccal Mucosa Squamous Cell Carcinoma
- +11 more
- Computed Tomography (CT)
- +5 more
-
Tucson, Arizona
- +71 more
Jan 11, 2023
Head Neck Cancer, Hypoxia, FMISO Trial in Brno, Olomouc, Ostrava (Dose escalation)
Active, not recruiting
- Head and Neck Cancer
- +3 more
- Dose escalation
-
Brno, Czechia
- +2 more
May 5, 2022
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Head Neck Cancer Trial in Amsterdam (radiation in Squamous Head and Neck Cancer)
Completed
- Head and Neck Cancer
- radiation in Squamous Head and Neck Cancer
-
Amsterdam, Netherlandsthe Netherlands Cancer Instiute
Jun 26, 2019
Carcinoma, Adenoid Cystic, Head Neck Cancer Trial in Pavia (simultaneous integrated boost of carbon ions radiation therapy)
Not yet recruiting
- Carcinoma, Adenoid Cystic
- Head and Neck Cancer
- simultaneous integrated boost of carbon ions radiation therapy
-
Pavia, ItalyCNAO
Feb 8, 2023
Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell
Active, not recruiting
- Head and Neck Carcinoma of Unknown Primary
- +19 more
- Berzosertib
- +3 more
-
Duarte, California
- +18 more
Aug 24, 2022
Pancreatic Cancer Trial in Jacksonville, Warrenville, Fairfax (radiation, drug, procedure)
Recruiting
- Pancreatic Cancer
- Proton Radiation
- +2 more
-
Jacksonville, Florida
- +2 more
Oct 24, 2021
Head-and-neck Cancer, Carcinoma of Unknown Primary Trial in Shanghai (Elective mucosal irradiaton)
Unknown status
- Head-and-neck Cancer
- Carcinoma of Unknown Primary
- Elective mucosal irradiaton
-
Shanghai, Shanghai, China
- +1 more
Apr 7, 2019